LON:OBI

Ondine Biomedical (OBI) Share Price, News & Analysis

Ondine Biomedical logo
C$8.65 0.00 (0.00%)
As of 03:22 PM Eastern

About Ondine Biomedical Stock (LON:OBI)

Advanced

Key Stats

Today's Range
C$8.61
▼
C$8.80
50-Day Range
C$8.65
▼
C$11.25
52-Week Range
C$7.50
▼
C$15.50
Volume
212,500 shs
Average Volume
574,355 shs
Market Capitalization
C$5.72 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.

Receive OBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OBI Stock News Headlines

Ondine Biomedical (LON:OBI) Shares Climb 0.6% - Here's What Happened
You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
Ondine Biomedical study reveals impact of 'infection tax'
See More Headlines

OBI Stock Analysis - Frequently Asked Questions

Ondine Biomedical's stock was trading at C$8.75 at the beginning of the year. Since then, OBI stock has decreased by 1.1% and is now trading at C$8.65.

Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
LON:OBI
Previous Symbol
LON:OBI
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($6.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$424.66 thousand
Net Margins
-1,150.26%
Pretax Margin
N/A
Return on Equity
-24,731.60%
Return on Assets
-159.71%

Debt

Debt-to-Equity Ratio
-8.65
Current Ratio
0.65
Quick Ratio
8.26

Sales & Book Value

Annual Sales
C$2.88 million
Price / Sales
1,976.99
Cash Flow
C$4.32 per share
Price / Cash Flow
1.99
Book Value
C$0.01 per share
Price / Book
996.57

Miscellaneous

Outstanding Shares
661,218,000
Free Float
N/A
Market Cap
C$5.69 billion
Optionable
Not Optionable
Beta
0.30
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:OBI) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners